E

ENB Therapeutics

8 employees

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Medical
Nanotechnology
Pharmaceuticals

Date founded

2015

Funding rounds raised

Total raised

$8.1M

from 5 investors over 5 rounds

E

ENB Therapeutics raised $8.1M on September 20, 2018

Investors: Remiges Ventures, Inc. and BioAdvance

E

ENB Therapeutics raised undisclosed on April 25, 2017

Investors: Pipeline Angels

E

ENB Therapeutics raised $110K on March 10, 2017

Investors: AJI Capital and Accelerate NY Seed Fund

FAQ